Resmetirom Poised to Become First NASH Treatment
Phase III study demonstrated drug is effective in resolving NASH and improving liver fibrosis
Source: medpagetoday.com
Stay updated with breaking news from Developer Madrigal Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase III study demonstrated drug is effective in resolving NASH and improving liver fibrosis
'This is yet another reason endocrinologists should get involved in fatty liver disease'